Free Trial

NeuroSense Therapeutics (NRSNW) News Today

$0.25 +0.05 (+25.00%)
As of 01/30/2025 01:23 PM Eastern
No headlines for this company have been tracked by MarketBeat.com
Get NeuroSense Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRSNW and its competitors with MarketBeat's FREE daily newsletter.

NRSNW Media Mentions By Week

NRSNW Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NRSNW
News Sentiment

1.89

0.71

Average
Medical
News Sentiment

NRSNW News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NRSNW Articles
This Week

1

0

NRSNW Articles
Average Week

Get NeuroSense Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRSNW and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:NRSNW) was last updated on 1/31/2025 by MarketBeat.com Staff
From Our Partners